openPR Logo
Press release

Global Dendritic Cell Cancer Vaccine Market is expected to grow at a substantial pace

12-09-2020 11:02 AM CET | Health & Medicine

Press release from: worldwidemarketreports

Overview:
Dendritic cells (DCs) are antigen-presenting cells that assist in the body's immune response initiation and regulation. Abnormal proliferating cells marked by different surface antigens are cancer cells. For cancer immunotherapy, dendritic cells are used to identify a cancer cell and then start the phagocytosis process against those targeted cancer cells. In nature, dendritic cells are adaptable. Dendritic cell vaccines became one of the most promising approaches as it works by boosting up the immune system which in turn will cause no or minimal side effects. Dendritic cell vaccines are unique of its kind which is specifically approved for advanced stages of cancer.

Drivers:
Rise in investments in research and development activities in healthcare sector is expected to drive growth of the global dendritic cell cancer vaccine market.

For instance, According to the Centers for Medicare & Medicaid Services (CMS), healthcare cost the United States US$3.6 trillion in 2018 which comprised 42% of global-wide spending on healthcare.

Regulatory approvals of vaccines by the government authorities is expected to drive growth of the global dendritic cell cancer vaccine market.

For instance, in June 2018, Northwest BioTherapeutics received the U.S. Food & Drug Administration (FDA) approval for its dendritic cell vaccine, DCVax – L. It is being used for the treatment of cancer type, glioblastoma.

Request for Exclusive sample report here https://www.worldwidemarketreports.com/sample/476450

Restraints:
Strict government rules and regulations are expected to restrain growth of global dendritic cell cancer Vaccine market. Furthermore, shortage of skilled professionals is expected to restrain the growth of the global dendritic cell cancer vaccine market.

Regional insights:
Asia Pacific is expected to dominate the global dendritic cell cancer vaccine market due to high investments made by governments of each emerging countries in this region such as India and china in the healthcare sector. According to the India Brand Equity Foundation (IBEF), hospitals and diagnostic centers attracted Foreign Direct Investment (FDI) worth US$ 6.72 billion between April 2000 and March 2020. According to the same source, The Government of India aims to increase healthcare spending expenditure to 3% of the Gross Domestic Product (GDP) by 2022.
North America dominates the global dendritic cell cancer vaccine market due to the awareness among people regarding cancer treatment and the availability of well-developed healthcare infrastructure and research institutions.

Competitive section:
Key competitors in global dendritic cell cancer vaccine market are Batavia Bioservices, EnoChian Biosciences, Merck KGaA, DC Prime, Tella Incorporation, CiMaas, ImmunoCellular Therapeutics, Northwest Biotherapeutics, Activarti, and GlaxoSmithKline plc.

In May 2020, Lineage Cell Therapeutics Inc., developed a vaccine for COVID-19 with help of allogeneic dendritic cell.

In June 2020, NW Biotherapeutics Inc., developed personalized immune therapy for solid tumour cancer. It has entered the phase of the clinical trial.

In May 2020, OSE Immunotherapeutics announced that new preclinical data identified a novel myeloid immune checkpoint target for cancer immunotherapy.

If you have any questions on this report, please reach out to us @ https://www.worldwidemarketreports.com/quiry/476450

Contact Us:

Mr. Shah
Worldwide Market Reports
Seattle, WA 98154,
U.S.
Email: sales@worldwidemarketreports.com

Worldwide Market Reports provides customized upon request. This report can be personalized to suit your needs. Please contact the research team to ensure you receive the report that fits your needs.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Dendritic Cell Cancer Vaccine Market is expected to grow at a substantial pace here

News-ID: 2205479 • Views:

More Releases from worldwidemarketreports

What are the different trends in Cash Logistics Market to boost its growth?
What are the different trends in Cash Logistics Market to boost its growth?
WorldwideMarket Reports has announced the addition of the “Cash Logistics Market to 2026”, the report classifies the global Cash Logistics Market in a precise manner to offer unearth valuable, accurate and reliable data insights that help organizations to meet their business objectives and enable growth This report studies the global Cash Logistics market, analyzes and researches the Cash Logistics development status and forecast in United States, EU, Japan, China, India and
Robo-Taxi Market is expected to register a modest increase in the near-term asse …
A robotaxi also known as a self-driving taxi or a driverless taxi, is an autonomous car (SAE automation level 4 or 5) operated for a ridesharing company . The fact of eliminating the need for a human driver or chauffeur, which represents a significant part of the operating costs of that type of services, could make it a very affordable solution for the customers and accelerate the spreading of Transportation-as-a-Service
Life Support Systems Market Expected to Beat Earnings Estimates
A life-support system is the combination of equipment that allows survival in an environment or situation that would not support that life in its absence. It is generally applied to systems supporting human life in situations where the outside environment is hostile, such as in space or underwater, or medical situations where the health of the person is compromised to the extent that the risk of death would be high
Why 2021's ketone market has made young investors ‘excessively optimistic
In chemistry, a ketone is a functional group with the structure R2C=O, where R can be a variety of carbon-containing substituents. Ketones contain a carbonyl group (a carbon-oxygen double bond). The simplest ketone is acetone (R = R' = methyl), with the formula CH3C(O)CH3. Many ketones are of great importance in industry and in biology. Examples include many sugars (ketoses), many steroids (e.g., testosterone), and the solvent acetone. The ketone

All 5 Releases


More Releases for Dendritic

Global Dendritic Cell Cancer Vaccine Market Outlook 2020 Report
“Global Dendritic Cell Cancer Vaccine Market Outlook 2020” Report highlights: * Introduction & Mechanism of Action of Dendritic Cells * New Vaccine Strategies That Exploit Dendritic Cells Biochemistry * Dendritic Cell Cancer Vaccine Market & Clinical Insight * Comparative Insight of Dendritic Cell Vaccines & Other Class of Vaccines * Dendritic Cell Cancer Vaccine Pipeline by Country, Company, Indication & Phase * Dendritic Cell Cancer Vaccine Clinical Pipeline: 58 Vaccines * Majority in Phase I/II
Download Dendritic Cell Cancer Vaccine Market & Clinical Trials Insight Report
Cancer is a disease caused by the uncontrolled division of the normal body cell, when these cells lose their property of contact inhibition or the ability to know when to stop dividing, they become cancerous. A vaccine generally aims at activating the immune cells to fight against a particular antigen. This specificity of the vaccination to target and kill the infected cells is responsible for its healing property. However the
Dendritic Cell Cancer Vaccine Market Dendritic Cell Cancer Vaccine Clinical Pipe …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Advent of Dendritic Vaccine in Oncology 2. Cataloging towards Dendritic Cells 3. Dendritic Cells Mechanizing Immune Response 3.1 Antigen Appearance Leads to Cellular Immune Responses 3.2 Stacking of Distinct Antigens over Dendritic Cells 3.3 Dendritic Cells Source and Subsets 3.4 Trail towards Maturation 3.5 Stimulation Initiates Maturation 3.6 Migration to Lymph Node 3.7
Global Dendritic Cell Cancer Vaccine Market & Dendritic Cell Cancer Vaccine Clin …
Dendritic cell first discovered in the early 19th century by Paul Langerhans and their further study and the role it plays in immune system conducted by M. Steinman in 1973, has only received the must deserved attention as a vaccine molecule, in general and as a cancer therapeutics, in particular in the recent past years. There was a widespread skepticism regarding its potential as a vaccine in the scientific community
Dendritic Cell Cancer Vaccine Market Sales Revenue Clinical Trials Pipeline Repo …
Dendritic cells are branched cells found in lymphoid organs and they are responsible for antigen display and T-cell activation. Antigen display presents the identity of pathogen to T-cells for their identification and elimination from the body. In 1868, Paul Langerhans discovered dendritic cells and thought that they are part of nervous system because of their branched structure. Until 1973 their identity was mistaken, Ralph Steinman and Zanvil Cohn identified them
Dendritic Cell Cancer Vaccine Market & Clinical Insight
Dendritic cells are branched cells found in lymphoid organs and they are responsible for antigen display and T-cell activation. Antigen display presents the identity of pathogen to T-cells for their identification and elimination from the body. In 1868, Paul Langerhans discovered dendritic cells and thought that they are part of nervous system because of their branched structure. Until 1973 their identity was mistaken, Ralph Steinman and Zanvil Cohn identified them